Jinekoloji ve Obstetrik Dergisi, cilt.20, sa.4, ss.207-212, 2006 (Scopus, TRDizin)
AIM: In this study, the aim was to determine if there is an association between matrix metalloprotcinase-1 (MMP-1) gene promoter polymorphism and ovarian cancer. STUDY DESING: The blood samples were collected from 42 cases of ovarian cancer and from 43 aged matched control subject. PCR and RFLP tecniques were used to determine insertion-deletion (2G/1G) polymorphism in MMP-1 promoter. RESULTS: Genotype frequencies were 2G/2G 78.6 %; 2G/G 21.4 %; G/G % 0 in the patients and 2G/2G 79.1 %; 2G/G 20.9 %: G/G 0 % in the healthy controls. The genotypes did not differ between cases and controls (p>0.05). The distribution of genotypes was in Hardy-Weinherg equilibrium. Allele frequencies were 89.5 % in controls and 89.3 % in cases for 2G allel. There was no relationship between MMP-1 genotype and tumor behavior (invasive-borderline) or tumor stage (early-advance). CONCLUSION: The results show that there was no relationship between MMP-1 promoter polymorphism and ovarian cancer in Turkish population.